Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
-
Second Sight Medical (EYES) Tops Q4 EPS by 2c
-
Second Sight Reports Fourth Quarter and Full Year 2019 Financial Results
-
Second Sight Medical (EYES) Reports In-Line Q3 EPS
-
Second Sight Reports Third Quarter 2019 Financial Results
-
Second Sight Reports Second Quarter 2019 Financial Results
-
Second Sight Medical (EYES) Announces Researchers Present Latest Positive Results of Orion Visual Cortical Prosthesis Feasibility Study
-
Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study
-
Second Sight Reports First Quarter 2019 Financial Results
-
Second Sight Medical (EYES) to Accelerate Development of Orion Visual Cortical Prosthesis System
-
Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System
-
Second Sight Medical (EYES) PT Lowered to $2.50 at H.C. Wainwright
-
Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results
-
Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call
-
Second Sight Medical Products, Inc. Announces Completion of Rights Offering
-
Second Sight Medical (EYES) Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
-
Second Sight Medical (EYES) Sees FY Revenue of $6.5-$6.9 million
-
Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
-
Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
-
Second Sight Reports Fourth Quarter 2018 Business Update
-
Second Sight Reports Fourth Quarter 2018 Business Update
-
Second Sight to Present at Digital Medicine and Medtech Showcase 2019
-
Second Sight to Present at Digital Medicine and Medtech Showcase 2019
-
Second Sight Medical (EYES) Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman
-
Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th
-
Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th
-
Second Sight Reports Third Quarter 2018 Financial Results
-
Second Sight Reports Third Quarter 2018 Financial Results
-
Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System
-
Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System
-
Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call
-
Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight Medical (EYES) Secures $1.8M Grant from National Institutes of Health to Support Orion Clinical Development
-
Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
-
Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
-
Second Sight Appoints Pat Ryan Chief Operating Officer
-
Second Sight to Present at Investor Conferences in September
-
Second Sight Medical (EYES) Completes $5M Private Placement of Common Stock with Gregg Williams, Chairman
-
Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight Reports Second Quarter 2018 Financial Results
-
Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call
-
Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference
-
Second Sight Reports First Quarter 2018 Financial Results
-
Second Sight Medical (EYES) Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman
-
Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call
-
Second Sight Medical (EYES) Announces Dr. Robert Greenberg's Resignation from Board of Directors
-
Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company

